This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, S. A.
Right arrow Articles by Carbone, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, S. A.
Right arrow Articles by Carbone, K. M.

 Previous Article  |  Next Article 

Journal of Virology, October 1998, p. 8037-8042, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Comparison of the Neurovirulence of a Vaccine and a Wild-Type Mumps Virus Strain in the Developing Rat Brain

Steven A. Rubin,1 Mikhail Pletnikov,2 and Kathryn M. Carbone1,2,3,*

DVP/OVRR, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892,1 and Departments of Psychiatry2 and Medicine,3 Johns Hopkins University, Baltimore, Maryland 21205

Received 6 May 1998/Accepted 25 June 1998

Prior to the adoption of widespread vaccination programs, mumps virus was the leading cause of virus-induced central nervous system (CNS) disease. Mumps virus-associated CNS complications in vaccinees continue to be reported; outside the United States, some of these complications have been attributed to vaccination with insufficiently attenuated neurovirulent vaccine strains. The development of potentially neurovirulent, live, attenuated mumps virus vaccines stems largely from the lack of an animal model that can reliably predict the neurovirulence of mumps virus vaccine candidates in humans. The lack of an effective safety test with which to measure mumps virus neurovirulence has also hindered analysis of the neuropathogenesis of mumps virus infection and the identification of molecular determinants of neurovirulence. In this report we show, for the first time, that mumps virus infection of the neonatal rat leads to developmental abnormalities in the cerebellum due to cerebellar granule cell migration defects. The incidence of the cerebellar abnormalities and other neuropathological and clinical outcomes of mumps virus infection of the neonatal rat brain demonstrated the ability of this model to distinguish neurovirulent (Kilham) from nonneurovirulent (Jeryl Lynn) mumps virus strains. Thus, this neonatal rat model may prove useful in evaluating the neurovirulence potential of new live, attenuated vaccine strains and may also be of value in elucidating the molecular basis of mumps virus neurovirulence.


* Corresponding author. Mailing address: DVP/OVRR/CBER/FDA, Building 29A, Room 1A-21, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 827-1973. Fax: (301) 480-5679. E-mail: carbonek{at}a1.cber.fda.gov.


Journal of Virology, October 1998, p. 8037-8042, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lemon, K., Rima, B. K., McQuaid, S., Allen, I. V., Duprex, W. P. (2007). The F Gene of Rodent Brain-Adapted Mumps Virus Is a Major Determinant of Neurovirulence. J. Virol. 81: 8293-8302 [Abstract] [Full Text]  
  • Clarke, D. K., Nasar, F., Lee, M., Johnson, J. E., Wright, K., Calderon, P., Guo, M., Natuk, R., Cooper, D., Hendry, R. M., Udem, S. A. (2007). Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations. J. Virol. 81: 2056-2064 [Abstract] [Full Text]  
  • Wilson, R. L., Fuentes, S. M., Wang, P., Taddeo, E. C., Klatt, A., Henderson, A. J., He, B. (2006). Function of Small Hydrophobic Proteins of Paramyxovirus. J. Virol. 80: 1700-1709 [Abstract] [Full Text]  
  • Rubin, S. A., Amexis, G., Pletnikov, M., Vanderzanden, J., Mauldin, J., Sauder, C., Malik, T., Chumakov, K., Carbone, K. M. (2003). Changes in Mumps Virus Gene Sequence Associated with Variability in Neurovirulent Phenotype. J. Virol. 77: 11616-11624 [Abstract] [Full Text]  
  • Orvell, C., Tecle, T., Johansson, B., Saito, H., Samuelson, A. (2002). Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J. Gen. Virol. 83: 2489-2496 [Abstract] [Full Text]  
  • Tecle, T., Bottiger, B., Orvell, C., Johansson, B. (2001). Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J. Gen. Virol. 82: 2675-2680 [Abstract] [Full Text]  
  • Rubin, S. A., Pletnikov, M., Taffs, R., Snoy, P. J., Kobasa, D., Brown, E. G., Wright, K. E., Carbone, K. M. (2000). Evaluation of a Neonatal Rat Model for Prediction of Mumps Virus Neurovirulence in Humans. J. Virol. 74: 5382-5384 [Abstract] [Full Text]  
  • Duprex, W. P., Duffy, I., McQuaid, S., Hamill, L., Cosby, S. L., Billeter, M. A., Schneider-Schaulies, J., ter Meulen, V., Rima, B. K. (1999). The H Gene of Rodent Brain-Adapted Measles Virus Confers Neurovirulence to the Edmonston Vaccine Strain. J. Virol. 73: 6916-6922 [Abstract] [Full Text]